Oncternal Therapeutics, Inc. (ONCT)

USD 0.53

(-24.12%)

Revenue Summary of Oncternal Therapeutics, Inc.

  • Oncternal Therapeutics, Inc.'s latest annual revenue in 2023 was 785 Thousand USD , down -47.32% from previous year.
  • Oncternal Therapeutics, Inc.'s latest quarterly revenue in 2024 Q2 was 801 Thousand USD , up 40.77% from previous quarter.
  • Oncternal Therapeutics, Inc. reported a annual revenue of 1.49 Million USD in annual revenue 2022, down -65.47% from previous year.
  • Oncternal Therapeutics, Inc. reported a annual revenue of 4.31 Million USD in annual revenue 2021, up 27.85% from previous year.
  • Oncternal Therapeutics, Inc. reported a quarterly revenue of 801 Thousand USD for 2024 Q2, up 40.77% from previous quarter.
  • Oncternal Therapeutics, Inc. reported a quarterly revenue of 106 Thousand USD for 2023 Q2, down -47.78% from previous quarter.

Annual Revenue Chart of Oncternal Therapeutics, Inc. (2023 - 1999)

Historical Annual Revenue of Oncternal Therapeutics, Inc. (2023 - 1999)

Year Revenue Revenue Growth
2023 785 Thousand USD -47.32%
2022 1.49 Million USD -65.47%
2021 4.31 Million USD 27.85%
2020 3.37 Million USD 39.18%
2019 2.42 Million USD -3.81%
2018 2.52 Million USD 50.6%
2017 1.67 Million USD 166.67%
2016 -2.51 Million USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD -100.0%
2011 14.73 Million USD -75.68%
2010 60.61 Million USD 311.49%
2009 14.73 Million USD 8.89%
2008 13.52 Million USD 89.84%
2007 7.12 Million USD -5.05%
2006 7.5 Million USD 98.44%
2005 3.78 Million USD 102.57%
2004 1.86 Million USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%

Peer Revenue Comparison of Oncternal Therapeutics, Inc.

Name Revenue Revenue Difference
AbCellera Biologics Inc. 38.02 Million USD 97.936%
Alkermes plc 1.66 Billion USD 99.953%
Agenus Inc. 156.31 Million USD 99.498%
Aptorum Group Limited 431.37 Thousand USD -81.975%
Ardelyx, Inc. 124.45 Million USD 99.369%
Dyadic International, Inc. 2.89 Million USD 72.92%
Eton Pharmaceuticals, Inc. 31.64 Million USD 97.519%
Lantern Pharma Inc. - USD -Infinity%
Inhibikase Therapeutics, Inc. 260.5 Thousand USD -201.344%
Novavax, Inc. 983.7 Million USD 99.92%
Janux Therapeutics, Inc. 8.08 Million USD 90.288%
Pyxis Oncology, Inc. - USD -Infinity%
TransCode Therapeutics, Inc. - USD -Infinity%
Ocuphire Pharma, Inc. 19.04 Million USD 95.879%
Outlook Therapeutics, Inc. - USD -Infinity%
Madrigal Pharmaceuticals, Inc. - USD -Infinity%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
SELLAS Life Sciences Group, Inc. - USD -Infinity%
Syros Pharmaceuticals, Inc. 9.93 Million USD 92.099%
Barinthus Biotherapeutics plc 802 Thousand USD 2.12%
Windtree Therapeutics, Inc. - USD -Infinity%
Xeris Biopharma Holdings, Inc. 163.91 Million USD 99.521%
Clearside Biomedical, Inc. 8.22 Million USD 90.457%
C4 Therapeutics, Inc. 20.75 Million USD 96.218%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 99.957%
AlloVir, Inc. - USD -Infinity%
Arrowhead Pharmaceuticals, Inc. 240.73 Million USD 99.674%
VYNE Therapeutics Inc. 424 Thousand USD -85.142%
Bicycle Therapeutics plc 26.97 Million USD 97.09%
BioXcel Therapeutics, Inc. 1.38 Million USD 43.116%
ChromaDex Corporation 83.57 Million USD 99.061%
Chimerix, Inc. 324 Thousand USD -142.284%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Caribou Biosciences, Inc. 34.47 Million USD 97.723%
CRISPR Therapeutics AG 371.2 Million USD 99.789%
Precision BioSciences, Inc. 48.72 Million USD 98.389%
Fate Therapeutics, Inc. 63.53 Million USD 98.764%
Fortress Biotech, Inc. 84.51 Million USD 99.071%
Fortress Biotech, Inc. 84.51 Million USD 99.071%
HOOKIPA Pharma Inc. 20.12 Million USD 96.1%
ImmuCell Corporation 17.47 Million USD 95.507%
IDEAYA Biosciences, Inc. 23.38 Million USD 96.643%
Immix Biopharma, Inc. - USD -Infinity%
Incyte Corporation 3.69 Billion USD 99.979%
Innoviva, Inc. 310.46 Million USD 99.747%
IO Biotech, Inc. - USD -Infinity%
Jaguar Health, Inc. 9.76 Million USD 91.958%
Keros Therapeutics, Inc. 151 Thousand USD -419.868%
Ligand Pharmaceuticals Incorporated 131.31 Million USD 99.402%
ContextLogic Inc. 287 Million USD 99.726%
MiMedx Group, Inc. 321.47 Million USD 99.756%
MEI Pharma, Inc. 65.29 Million USD 98.798%
NextCure, Inc. - USD -Infinity%
Onconetix, Inc. 58.46 Thousand USD -1242.684%
Opthea Limited 261.85 Thousand USD -199.78%
Psyence Biomedical Ltd. - USD -Infinity%
Vaxcyte, Inc. - USD -Infinity%
PDS Biotechnology Corporation - USD -Infinity%
Precigen, Inc. 6.22 Million USD 87.39%
Pharming Group N.V. 245.31 Million USD 99.68%
Phathom Pharmaceuticals, Inc. 682 Thousand USD -15.103%
Pieris Pharmaceuticals, Inc. 42.81 Million USD 98.166%
PureTech Health plc 3.33 Million USD 76.426%
Rigel Pharmaceuticals, Inc. 116.88 Million USD 99.328%
Avidity Biosciences, Inc. 9.56 Million USD 91.789%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Sangamo Therapeutics, Inc. 176.23 Million USD 99.555%
Sol-Gel Technologies Ltd. 1.55 Million USD 49.485%
Acelyrin, Inc. - USD -Infinity%
Salarius Pharmaceuticals, Inc. - USD -Infinity%
Summit Therapeutics Inc. - USD -Infinity%
Sensei Biotherapeutics, Inc. - USD -Infinity%
Senti Biosciences, Inc. 2.56 Million USD 69.348%
Stoke Therapeutics, Inc. 8.78 Million USD 91.059%
Elevation Oncology, Inc. - USD -Infinity%
Alaunos Therapeutics, Inc. 5000.00 USD -15600.0%
Telomir Pharmaceuticals, Inc. Common Stock - USD -Infinity%
Entrada Therapeutics, Inc. 129.01 Million USD 99.392%
VistaGen Therapeutics, Inc. 1.06 Million USD 26.222%
Kintara Therapeutics, Inc. - USD -Infinity%
Wave Life Sciences Ltd. 113.3 Million USD 99.307%
Seer, Inc. 15.18 Million USD 94.829%
Verrica Pharmaceuticals Inc. 5.12 Million USD 84.68%
Aadi Bioscience, Inc. 24.35 Million USD 96.777%
ESSA Pharma Inc. - USD -Infinity%
GlycoMimetics, Inc. 10 Thousand USD -7750.0%
GT Biopharma, Inc. - USD -Infinity%
Inhibrx Biosciences, Inc. 1.8 Million USD 56.389%
Akebia Therapeutics, Inc. 194.62 Million USD 99.597%
Catalyst Pharmaceuticals, Inc. 398.2 Million USD 99.803%
Longboard Pharmaceuticals, Inc. - USD -Infinity%
Orchestra BioMed Holdings, Inc. 2.76 Million USD 71.558%
Alzamend Neuro, Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 62.83 Million USD 98.751%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 93.483%
Viracta Therapeutics, Inc. - USD -Infinity%
Rocket Pharmaceuticals, Inc. - USD -Infinity%
Aptose Biosciences Inc. - USD -Infinity%
ZyVersa Therapeutics, Inc. - USD -Infinity%
Soligenix, Inc. 839.35 Thousand USD 6.476%
Century Therapeutics, Inc. 2.23 Million USD 64.877%
Kura Oncology, Inc. - USD -Infinity%
TScan Therapeutics, Inc. 21.04 Million USD 96.271%
Intensity Therapeutics, Inc. - USD -Infinity%
Ocean Biomedical, Inc. - USD -Infinity%
CytomX Therapeutics, Inc. 101.21 Million USD 99.224%
Autolus Therapeutics plc 1.69 Million USD 53.769%
Mineralys Therapeutics, Inc. - USD -Infinity%
EyePoint Pharmaceuticals, Inc. 46.01 Million USD 98.294%
Eterna Therapeutics Inc. 68 Thousand USD -1054.412%
Adaptive Biotechnologies Corporation 170.27 Million USD 99.539%
GRI Bio, Inc. 21.76 Million USD 96.394%
Xenetic Biosciences, Inc. 2.53 Million USD 69.094%
Tenaya Therapeutics, Inc. - USD -Infinity%
IGM Biosciences, Inc. 2.13 Million USD 63.146%
INmune Bio, Inc. 155 Thousand USD -406.452%
Heron Therapeutics, Inc. 127.04 Million USD 99.382%
SAB Biotherapeutics, Inc. 2.23 Million USD 64.94%
Pasithea Therapeutics Corp. - USD -Infinity%
Entero Therapeutics, Inc. - USD -Infinity%
Milestone Pharmaceuticals Inc. 1 Million USD 21.5%
X4 Pharmaceuticals, Inc. - USD -Infinity%
Atara Biotherapeutics, Inc. 8.57 Million USD 90.843%
Coherus BioSciences, Inc. 257.24 Million USD 99.695%
Verastem, Inc. - USD -Infinity%
Abeona Therapeutics Inc. 3.5 Million USD 77.571%
Pliant Therapeutics, Inc. 1.58 Million USD 50.316%
Tonix Pharmaceuticals Holding Corp. 7.76 Million USD 89.894%
Histogen Inc. 3.76 Million USD 79.172%
Aprea Therapeutics, Inc. 583.23 Thousand USD -34.595%
Surrozen, Inc. - USD -Infinity%
Organovo Holdings, Inc. 109 Thousand USD -620.183%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Ovid Therapeutics Inc. 391.69 Thousand USD -100.411%
Panbela Therapeutics, Inc. - USD -Infinity%
CASI Pharmaceuticals, Inc. 33.87 Million USD 97.683%
Cadrenal Therapeutics, Inc. Common Stock - USD -Infinity%
Centessa Pharmaceuticals plc 6.85 Million USD 88.545%
Hepion Pharmaceuticals, Inc. - USD -Infinity%
Arcturus Therapeutics Holdings Inc. 157.74 Million USD 99.502%
BioRestorative Therapies, Inc. 145.8 Thousand USD -438.409%
Apollomics, Inc. 821 Thousand USD 4.385%
Amarin Corporation plc 306.91 Million USD 99.744%
Mesoblast Limited 5.9 Million USD 86.699%
Turnstone Biologics Corp. 19.3 Million USD 95.934%
Kymera Therapeutics, Inc. 78.59 Million USD 99.001%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd - USD -Infinity%
Aurinia Pharmaceuticals Inc. 175.51 Million USD 99.553%
BriaCell Therapeutics Corp. - USD -Infinity%
Monopar Therapeutics Inc. - USD -Infinity%
Exelixis, Inc. 1.83 Billion USD 99.957%
Better Therapeutics, Inc. - USD -Infinity%
Nurix Therapeutics, Inc. 76.98 Million USD 98.98%
Apellis Pharmaceuticals, Inc. 396.59 Million USD 99.802%
NLS Pharmaceutics AG - USD -Infinity%
Dermata Therapeutics, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Gritstone bio, Inc. 1.33 Million USD 41.022%
Jasper Therapeutics, Inc. - USD -Infinity%
TNF Pharmaceuticals, Inc. - USD -Infinity%
Avid Bioservices, Inc. 139.91 Million USD 99.439%
Insmed Incorporated 305.2 Million USD 99.743%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
MediWound Ltd. 18.68 Million USD 95.799%
OmniAb, Inc. 34.16 Million USD 97.702%
Alector, Inc. 97.06 Million USD 99.191%
Seres Therapeutics, Inc. 126.32 Million USD 99.379%
Checkpoint Therapeutics, Inc. 103 Thousand USD -662.136%
Zai Lab Limited 266.71 Million USD 99.706%
Revance Therapeutics, Inc. 234.04 Million USD 99.665%
Aura Biosciences, Inc. - USD -Infinity%
Lyell Immunopharma, Inc. 130 Thousand USD -503.846%
Immunic, Inc. - USD -Infinity%
Tarsus Pharmaceuticals, Inc. 17.44 Million USD 95.501%
Veracyte, Inc. 361.05 Million USD 99.783%
InMed Pharmaceuticals Inc. 4.59 Million USD 82.926%
FibroGen, Inc. 147.75 Million USD 99.469%
SeaStar Medical Holding Corporation - USD -Infinity%
Adial Pharmaceuticals, Inc. - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 147.8 Thousand USD -431.105%
Jazz Pharmaceuticals plc 3.83 Billion USD 99.98%
Cyclacel Pharmaceuticals, Inc. 420 Thousand USD -86.905%
Amylyx Pharmaceuticals, Inc. 380.78 Million USD 99.794%
TG Therapeutics, Inc. 233.66 Million USD 99.664%
Galecto, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Fortrea Holdings Inc. 3.1 Billion USD 99.975%
KalVista Pharmaceuticals, Inc. - USD -Infinity%
Aptevo Therapeutics Inc. - USD -Infinity%
XBiotech Inc. - USD -Infinity%
Jasper Therapeutics, Inc. - USD -Infinity%
Lyra Therapeutics, Inc. 1.55 Million USD 49.615%
Foghorn Therapeutics Inc. 34.15 Million USD 97.702%
Y-mAbs Therapeutics, Inc. 84.81 Million USD 99.074%
Theravance Biopharma, Inc. 57.42 Million USD 98.633%
Ultragenyx Pharmaceutical Inc. 434.24 Million USD 99.819%
Metagenomi, Inc. Common Stock 44.75 Million USD 98.246%
Vaxxinity, Inc. - USD -Infinity%
BioCryst Pharmaceuticals, Inc. 331.41 Million USD 99.763%
Gain Therapeutics, Inc. 55.18 Thousand USD -1322.617%
Cartesian Therapeutics, Inc. 26 Million USD 96.981%
NexImmune, Inc. - USD -Infinity%
Creative Medical Technology Holdings, Inc. 9000.00 USD -8622.222%
Marker Therapeutics, Inc. 3.31 Million USD 76.292%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 99.994%
Chemomab Therapeutics Ltd. - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
RAPT Therapeutics, Inc. - USD -Infinity%
Ainos, Inc. 122.11 Thousand USD -542.852%
Pluri Inc. 326 Thousand USD -140.798%
Prothena Corporation plc 91.37 Million USD 99.141%
Adaptimmune Therapeutics plc 60.28 Million USD 98.698%
Celularity Inc. 22.77 Million USD 96.553%
Rallybio Corporation - USD -Infinity%
Cue Biopharma, Inc. 5.49 Million USD 85.701%
MeiraGTx Holdings plc 14.01 Million USD 94.4%
Omeros Corporation - USD -Infinity%
Humacyte, Inc. - USD -Infinity%
Immunocore Holdings plc 249.42 Million USD 99.685%
Cocrystal Pharma, Inc. - USD -Infinity%
Cidara Therapeutics, Inc. 63.9 Million USD 98.772%
Blueprint Medicines Corporation 249.38 Million USD 99.685%
CalciMedica, Inc. - USD -Infinity%
Cabaletta Bio, Inc. - USD -Infinity%
Marinus Pharmaceuticals, Inc. 30.98 Million USD 97.467%
Scholar Rock Holding Corporation - USD -Infinity%
Sana Biotechnology, Inc. - USD -Infinity%
Pulmatrix, Inc. 7.29 Million USD 89.244%
Elicio Therapeutics, Inc. - USD -Infinity%
Vigil Neuroscience, Inc. - USD -Infinity%
Intellia Therapeutics, Inc. 36.27 Million USD 97.836%
Adlai Nortye Ltd. American Depositary Shares 4.99 Million USD 84.286%
Cytokinetics, Incorporated 7.53 Million USD 89.575%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Nutriband Inc. 2.08 Million USD 62.356%
Protara Therapeutics, Inc. - USD -Infinity%
Vor Biopharma Inc. - USD -Infinity%
Roivant Sciences Ltd. 124.79 Million USD 99.371%
Evogene Ltd. 5.64 Million USD 86.082%
ProKidney Corp. - USD -Infinity%
Applied Therapeutics, Inc. 9.99 Million USD 92.145%
Hoth Therapeutics, Inc. - USD -Infinity%
BridgeBio Pharma, Inc. 9.3 Million USD 91.562%
CorMedix Inc. - USD -Infinity%
BioLineRx Ltd. 4.8 Million USD 83.646%
Tango Therapeutics, Inc. 36.52 Million USD 97.851%
Galectin Therapeutics Inc. - USD -Infinity%
Atai Life Sciences N.V. 314 Thousand USD -150.0%
Renovaro Biosciences Inc. - USD -Infinity%
Aerovate Therapeutics, Inc. - USD -Infinity%
Zentalis Pharmaceuticals, Inc. - USD -Infinity%
Sagimet Biosciences Inc. 2 Million USD 60.75%
MediciNova, Inc. 1 Million USD 21.5%
Praxis Precision Medicines, Inc. 2.44 Million USD 67.92%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -4500.059%
GeoVax Labs, Inc. - USD -Infinity%
Axsome Therapeutics, Inc. 270.6 Million USD 99.71%
Biomea Fusion, Inc. - USD -Infinity%
PTC Therapeutics, Inc. 937.82 Million USD 99.916%
Mereo BioPharma Group plc 10 Million USD 92.15%
Cullinan Oncology, Inc. - USD -Infinity%
Syndax Pharmaceuticals, Inc. - USD -Infinity%
Absci Corporation 5.71 Million USD 86.271%
NRx Pharmaceuticals, Inc. - USD -Infinity%
4D Molecular Therapeutics, Inc. 20.72 Million USD 96.212%
Dyne Therapeutics, Inc. - USD -Infinity%
Kiniksa Pharmaceuticals, Ltd. 270.25 Million USD 99.71%
Ventyx Biosciences, Inc. - USD -Infinity%
Allakos Inc. - USD -Infinity%
Imunon, Inc. - USD -Infinity%
Fulcrum Therapeutics, Inc. 2.8 Million USD 72.014%
Corcept Therapeutics Incorporated 482.37 Million USD 99.837%
BioAtla, Inc. - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
Bio-Path Holdings, Inc. - USD -Infinity%
Allogene Therapeutics, Inc. 95 Thousand USD -726.316%
Larimar Therapeutics, Inc. - USD -Infinity%
XOMA Corporation 4.75 Million USD 83.501%
Kezar Life Sciences, Inc. 7 Million USD 88.786%
Cara Therapeutics, Inc. 20.96 Million USD 96.256%
aTyr Pharma, Inc. 353 Thousand USD -122.38%
Aligos Therapeutics, Inc. 15.52 Million USD 94.945%
Akero Therapeutics, Inc. - USD -Infinity%
Viridian Therapeutics, Inc. 314 Thousand USD -150.0%
Eliem Therapeutics, Inc. - USD -Infinity%
EyeGate Pharmaceuticals, Inc. 12.05 Thousand USD -6409.661%
Akari Therapeutics, Plc - USD -Infinity%
Tevogen Bio Holdings Inc. - USD -Infinity%
Halozyme Therapeutics, Inc. 829.25 Million USD 99.905%
Lexaria Bioscience Corp. 226.2 Thousand USD -247.026%
UroGen Pharma Ltd. 82.71 Million USD 99.051%
Sutro Biopharma, Inc. 153.73 Million USD 99.489%
ZIVO Bioscience, Inc. 27.65 Thousand USD -2739.06%
Orgenesis Inc. 530 Thousand USD -48.113%
Entera Bio Ltd. - USD -Infinity%
GH Research PLC - USD -Infinity%
Lisata Therapeutics, Inc. - USD -Infinity%
Reneo Pharmaceuticals, Inc. - USD -Infinity%
Xencor, Inc. 168.33 Million USD 99.534%
60 Degrees Pharmaceuticals, Inc. 253.57 Thousand USD -209.576%
Replimune Group, Inc. - USD -Infinity%
Coeptis Therapeutics Holdings, Inc. - USD -Infinity%
Vanda Pharmaceuticals Inc. 192.64 Million USD 99.593%
Lexaria Bioscience Corp. 226.2 Thousand USD -247.026%
Portage Biotech Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -4500.059%
Olema Pharmaceuticals, Inc. - USD -Infinity%
OncoCyte Corporation 1.5 Million USD 47.771%
Qualigen Therapeutics, Inc. 5.2 Million USD 84.918%
Processa Pharmaceuticals, Inc. - USD -Infinity%
Purple Biotech Ltd. - USD -Infinity%
CollPlant Biotechnologies Ltd. 10.95 Million USD 92.837%
scPharmaceuticals Inc. 13.59 Million USD 94.225%
ProMIS Neurosciences, Inc. - USD -Infinity%
HilleVax, Inc. - USD -Infinity%
NeuroSense Therapeutics Ltd. - USD -Infinity%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
Neumora Therapeutics, Inc. Common Stock - USD -Infinity%
Atossa Therapeutics, Inc. - USD -Infinity%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Savara Inc. - USD -Infinity%
Curis, Inc. 10.02 Million USD 92.168%
Daré Bioscience, Inc. 2.8 Million USD 72.043%
Carmell Therapeutics Corporation - USD -Infinity%
Titan Pharmaceuticals, Inc. 184 Thousand USD -326.63%
Achieve Life Sciences, Inc. - USD -Infinity%
BeiGene, Ltd. 2.45 Billion USD 99.968%
Kiromic BioPharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. Warrant 11.58 Million USD 93.221%
Protagonist Therapeutics, Inc. 60 Million USD 98.692%
Erasca, Inc. - USD -Infinity%
bluebird bio, Inc. 29.49 Million USD 97.339%
Protagenic Therapeutics, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 99.968%
DBV Technologies S.A. 15.72 Million USD 95.009%
Protagenic Therapeutics, Inc. - USD -Infinity%
Moderna, Inc. 6.84 Billion USD 99.989%
Vincerx Pharma, Inc. - USD -Infinity%
Fresh Tracks Therapeutics, Inc. 8 Million USD 90.195%
Molecular Templates, Inc. 57.3 Million USD 98.63%
Acrivon Therapeutics, Inc. Common Stock - USD -Infinity%
Travere Therapeutics, Inc. 145.23 Million USD 99.46%
Monte Rosa Therapeutics, Inc. - USD -Infinity%
Spruce Biosciences, Inc. 10.08 Million USD 92.219%
Celldex Therapeutics, Inc. 6.88 Million USD 88.595%
Cogent Biosciences, Inc. - USD -Infinity%
MacroGenics, Inc. 58.74 Million USD 98.664%
RenovoRx, Inc. - USD -Infinity%
Adicet Bio, Inc. - USD -Infinity%
Prime Medicine, Inc. - USD -Infinity%
Aditxt, Inc. 645.17 Thousand USD -21.672%
Adagene Inc. 18.11 Million USD 95.666%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 27.449%
Maravai LifeSciences Holdings, Inc. 288.94 Million USD 99.728%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Voyager Therapeutics, Inc. 250 Million USD 99.686%
SciSparc Ltd. 2.87 Million USD 72.734%
Vericel Corporation 197.51 Million USD 99.603%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. - USD -Infinity%
Generation Bio Co. 5.9 Million USD 86.704%
Astria Therapeutics, Inc. - USD -Infinity%
Black Diamond Therapeutics, Inc. - USD -Infinity%
Arcutis Biotherapeutics, Inc. 59.6 Million USD 98.683%
Invivyd, Inc. - USD -Infinity%
Relay Therapeutics, Inc. 25.54 Million USD 96.927%
Quoin Pharmaceuticals, Ltd. - USD -Infinity%
Spero Therapeutics, Inc. 96.73 Million USD 99.189%
Artelo Biosciences, Inc. - USD -Infinity%
2seventy bio, Inc. 100.38 Million USD 99.218%
ADMA Biologics, Inc. 258.21 Million USD 99.696%
Clene Inc. 654 Thousand USD -20.031%
Capricor Therapeutics, Inc. 25.17 Million USD 96.882%
Boundless Bio, Inc. Common Stock - USD -Infinity%
GeoVax Labs, Inc. - USD -Infinity%
Recursion Pharmaceuticals, Inc. 44.57 Million USD 98.239%
Citius Pharmaceuticals, Inc. - USD -Infinity%
Contineum Therapeutics, Inc. Class A Common Stock 50 Million USD 98.43%
Relmada Therapeutics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. 107 Thousand USD -633.645%
ALX Oncology Holdings Inc. - USD -Infinity%
Vir Biotechnology, Inc. 86.18 Million USD 99.089%
Evaxion Biotech A/S 73.11 Thousand USD -973.695%
Ocular Therapeutix, Inc. 58.44 Million USD 98.657%
Verve Therapeutics, Inc. 11.75 Million USD 93.324%
Trevena, Inc. 3.12 Million USD 74.88%
Surrozen, Inc. - USD -Infinity%
Tyra Biosciences, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Galmed Pharmaceuticals Ltd. - USD -Infinity%
Unity Biotechnology, Inc. - USD -Infinity%
Tenax Therapeutics, Inc. - USD -Infinity%
Terns Pharmaceuticals, Inc. - USD -Infinity%
ACADIA Pharmaceuticals Inc. 726.43 Million USD 99.892%
Connect Biopharma Holdings Limited - USD -Infinity%
Clearmind Medicine Inc. - USD -Infinity%
Kronos Bio, Inc. 6.28 Million USD 87.516%
Bolt Biotherapeutics, Inc. 7.87 Million USD 90.033%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Viking Therapeutics, Inc. - USD -Infinity%
Statera Biopharma, Inc. - USD -Infinity%
ImmunityBio, Inc. 622 Thousand USD -26.206%
Korro Bio, Inc. - USD -Infinity%
Kineta, Inc. 5.44 Million USD 85.575%
BioVie Inc. - USD -Infinity%
Codexis, Inc. 70.14 Million USD 98.881%
Celularity Inc. 22.77 Million USD 96.553%
Crinetics Pharmaceuticals, Inc. 4.01 Million USD 80.439%
Celcuity Inc. - USD -Infinity%
Virax Biolabs Group Limited 156.41 Thousand USD -401.857%
Cibus, Inc. 1.81 Million USD 56.797%
Eledon Pharmaceuticals, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
IN8bio, Inc. - USD -Infinity%
Kodiak Sciences Inc. - USD -Infinity%
Annexon, Inc. - USD -Infinity%
Adverum Biotechnologies, Inc. 3.6 Million USD 78.194%
Assembly Biosciences, Inc. 7.16 Million USD 89.041%
Avalo Therapeutics, Inc. 1.92 Million USD 59.2%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 99.9%
Eyenovia, Inc. 3787.00 USD -20628.809%
Puma Biotechnology, Inc. 235.63 Million USD 99.667%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Xilio Therapeutics, Inc. - USD -Infinity%
Arcellx, Inc. 110.31 Million USD 99.288%
Cardiff Oncology, Inc. 488 Thousand USD -60.861%
Enanta Pharmaceuticals, Inc. 79.2 Million USD 99.009%
Regulus Therapeutics Inc. - USD -Infinity%
Moolec Science SA 905.04 Thousand USD 13.264%
Acumen Pharmaceuticals, Inc. - USD -Infinity%
Geron Corporation 237 Thousand USD -231.224%
LAVA Therapeutics N.V. 6.76 Million USD 88.403%
Royalty Pharma plc 2.35 Billion USD 99.967%
Atea Pharmaceuticals, Inc. - USD -Infinity%
Greenwich LifeSciences, Inc. - USD -Infinity%
TFF Pharmaceuticals, Inc. 733.87 Thousand USD -6.967%
Mersana Therapeutics, Inc. 36.85 Million USD 97.87%
Humacyte, Inc. - USD -Infinity%
Structure Therapeutics Inc. - USD -Infinity%
89bio, Inc. - USD -Infinity%
PMV Pharmaceuticals, Inc. - USD -Infinity%
Avenue Therapeutics, Inc. - USD -Infinity%
Genelux Corporation 170 Thousand USD -361.765%
Trevi Therapeutics, Inc. - USD -Infinity%
Lexicon Pharmaceuticals, Inc. 1.2 Million USD 34.801%
Notable Labs, Ltd. 310 Thousand USD -153.226%
Liquidia Corporation 17.48 Million USD 95.511%
Mustang Bio, Inc. - USD -Infinity%
Immunovant, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 27.449%
Arbutus Biopharma Corporation 18.14 Million USD 95.673%
DiaMedica Therapeutics Inc. - USD -Infinity%
Vera Therapeutics, Inc. 1.86 Million USD 57.841%
Acasti Pharma Inc. - USD -Infinity%
MiNK Therapeutics, Inc. - USD -Infinity%
Pasithea Therapeutics Corp. - USD -Infinity%
Xenon Pharmaceuticals Inc. - USD -Infinity%
Elevai Labs, Inc. Common Stock 1.71 Million USD 54.163%
NeuroBo Pharmaceuticals, Inc. - USD -Infinity%
Tempest Therapeutics, Inc. - USD -Infinity%
Soleno Therapeutics, Inc. - USD -Infinity%
PepGen Inc. - USD -Infinity%
Moleculin Biotech, Inc. - USD -Infinity%
United Therapeutics Corporation 2.32 Billion USD 99.966%
Nuvectis Pharma, Inc. - USD -Infinity%
Solid Biosciences Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Immuneering Corporation - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. 72.1 Thousand USD -988.735%
Belite Bio, Inc - USD -Infinity%
XOMA Corporation 4.75 Million USD 83.501%
ARS Pharmaceuticals, Inc. 30 Thousand USD -2516.667%
Bionomics Limited - USD -Infinity%
Apogee Therapeutics, Inc. - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
uniQure N.V. 15.84 Million USD 95.045%
Cassava Sciences, Inc. - USD -Infinity%
Estrella Immunopharma, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 64.7 Million USD 98.787%
Forte Biosciences, Inc. - USD -Infinity%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
Enlivex Therapeutics Ltd. - USD -Infinity%
Conduit Pharmaceuticals Inc. - USD -Infinity%
SeaStar Medical Holding Corporation - USD -Infinity%
FibroBiologics, Inc. Common Stock - USD -Infinity%
Altimmune, Inc. 426 Thousand USD -84.272%
Amicus Therapeutics, Inc. 399.35 Million USD 99.803%
Alpha Tau Medical Ltd. - USD -Infinity%
Compugen Ltd. 33.45 Million USD 97.654%
Peak Bio, Inc. 367.87 Thousand USD -113.387%
Zevra Therapeutics, Inc. 27.46 Million USD 97.141%
Benitec Biopharma Inc. 216 Thousand USD -263.426%
Spyre Therapeutics, Inc. 886 Thousand USD 11.4%
NKGen Biotech, Inc. Common Stock - USD -Infinity%
Zura Bio Limited - USD -Infinity%
PolyPid Ltd. - USD -Infinity%
Aileron Therapeutics, Inc. - USD -Infinity%
NKGen Biotech, Inc. Warrants - USD -Infinity%
Instil Bio, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.936%
Immunome, Inc. 14.01 Million USD 94.4%
Compass Therapeutics, Inc. - USD -Infinity%
Verona Pharma plc - USD -Infinity%
enGene Holdings Inc. Warrants - USD -Infinity%
Shattuck Labs, Inc. 1.65 Million USD 52.625%
CervoMed Inc. 7.14 Million USD 89.013%
LENZ Therapeutics, Inc. - USD -Infinity%
Plus Therapeutics, Inc. 4.91 Million USD 84.022%
Dianthus Therapeutics, Inc. 2.82 Million USD 72.222%
Moolec Science SA 905.04 Thousand USD 13.264%
Enveric Biosciences, Inc. - USD -Infinity%
Inovio Pharmaceuticals, Inc. 832.01 Thousand USD 5.65%
AnaptysBio, Inc. 17.15 Million USD 95.425%
Design Therapeutics, Inc. - USD -Infinity%
Leap Therapeutics, Inc. - USD -Infinity%
NeurAxis, Inc. 2.46 Million USD 68.09%
Seelos Therapeutics, Inc. 2.2 Million USD 64.367%
Lumos Pharma, Inc. 2.05 Million USD 61.726%
Achilles Therapeutics plc - USD -Infinity%
enGene Holdings Inc. Common Stock - USD -Infinity%
180 Life Sciences Corp. - USD -Infinity%
Opiant Pharmaceuticals, Inc. 40.72 Million USD 98.072%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Nutriband Inc. 2.08 Million USD 62.356%
ORIC Pharmaceuticals, Inc. - USD -Infinity%
CG Oncology, Inc. Common stock 204 Thousand USD -284.804%
Fractyl Health, Inc. Common Stock 120 Thousand USD -554.167%
Rani Therapeutics Holdings, Inc. - USD -Infinity%
MoonLake Immunotherapeutics - USD -Infinity%
Palisade Bio, Inc. 250 Thousand USD -214.0%
Tourmaline Bio, Inc. - USD -Infinity%
Beam Therapeutics Inc. 377.7 Million USD 99.792%
Neurogene Inc. - USD -Infinity%
Mirum Pharmaceuticals, Inc. 186.37 Million USD 99.579%
AEON Biopharma, Inc. - USD -Infinity%
CARGO Therapeutics, Inc. Common Stock - USD -Infinity%
Sesen Bio, Inc. 40 Million USD 98.038%
Enliven Therapeutics, Inc. - USD -Infinity%
Kiora Pharmaceuticals, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 1.18 Million USD 33.978%
Taysha Gene Therapies, Inc. 15.45 Million USD 94.919%
Athira Pharma, Inc. - USD -Infinity%
Vaccinex, Inc. 570 Thousand USD -37.719%
HCW Biologics Inc. 2.84 Million USD 72.377%
XOMA Corporation 4.75 Million USD 83.501%
Nektar Therapeutics 90.12 Million USD 99.129%
Arvinas, Inc. 78.5 Million USD 99.0%
Tevogen Bio Holdings Inc. - USD -Infinity%
Merus N.V. 43.94 Million USD 98.214%
Omega Therapeutics, Inc. 3.09 Million USD 74.628%
Quince Therapeutics, Inc. - USD -Infinity%
Rezolute, Inc. - USD -Infinity%
Clene Inc. 654 Thousand USD -20.031%
Indaptus Therapeutics, Inc. - USD -Infinity%
BeyondSpring Inc. 1.75 Million USD 55.168%
Synlogic, Inc. 3.37 Million USD 76.713%
Allarity Therapeutics, Inc. - USD -Infinity%
Phio Pharmaceuticals Corp. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD -113.387%
Werewolf Therapeutics, Inc. 19.94 Million USD 96.064%
Krystal Biotech, Inc. 50.69 Million USD 98.452%
Karyopharm Therapeutics Inc. 146.03 Million USD 99.462%
SpringWorks Therapeutics, Inc. 5.44 Million USD 85.588%
Lipella Pharmaceuticals Inc. 449.61 Thousand USD -74.593%
MannKind Corporation 198.96 Million USD 99.605%
Ikena Oncology, Inc. 9.16 Million USD 91.43%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 113.45 Million USD 99.308%
Gossamer Bio, Inc. - USD -Infinity%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Legend Biotech Corporation 285.14 Million USD 99.725%
Mural Oncology plc - USD -Infinity%
Biora Therapeutics, Inc. 4000.00 USD -19525.0%
PaxMedica, Inc. Common Stock - USD -Infinity%
Disc Medicine, Inc. - USD -Infinity%
Champions Oncology, Inc. 50.15 Million USD 98.435%
REGENXBIO Inc. 90.24 Million USD 99.13%
Ensysce Biosciences, Inc. 2.23 Million USD 64.806%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. - USD -Infinity%
Edgewise Therapeutics, Inc. - USD -Infinity%
Vaxart, Inc. 7.37 Million USD 89.362%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. - USD -Infinity%
Cellectis S.A. 755 Thousand USD -3.974%
Longeveron Inc. 709 Thousand USD -10.719%
Repare Therapeutics Inc. 51.13 Million USD 98.465%
Sarepta Therapeutics, Inc. 1.24 Billion USD 99.937%
Inozyme Pharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. 11.58 Million USD 93.221%
Nymox Pharmaceutical Corporation - USD -Infinity%
Third Harmonic Bio, Inc. - USD -Infinity%
ArriVent BioPharma, Inc. Common Stock - USD -Infinity%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 210 Thousand USD -273.81%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 99.992%
Denali Therapeutics Inc. 330.53 Million USD 99.763%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 16.29 Million USD 95.183%
Corvus Pharmaceuticals, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Passage Bio, Inc. - USD -Infinity%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. - USD -Infinity%
Day One Biopharmaceuticals, Inc. - USD -Infinity%
Oramed Pharmaceuticals Inc. 2.7 Million USD 70.958%
Scinai Immunotherapeutics Ltd. - USD -Infinity%
Rhythm Pharmaceuticals, Inc. 77.42 Million USD 98.986%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 152.43 Thousand USD -414.99%
Carisma Therapeutics, Inc. 14.91 Million USD 94.738%
Unicycive Therapeutics, Inc. 675 Thousand USD -16.296%
OmniAb, Inc. 34.16 Million USD 97.702%
Anew Medical, Inc. - USD -Infinity%
Fennec Pharmaceuticals Inc. 21.25 Million USD 96.306%
Lipocine Inc. -2.85 Million USD 127.536%
Lexeo Therapeutics, Inc. Common Stock - USD -Infinity%
Nautilus Biotechnology, Inc. - USD -Infinity%
SAB Biotherapeutics, Inc. 2.23 Million USD 64.94%
G1 Therapeutics, Inc. 82.51 Million USD 99.049%
Bellerophon Therapeutics, Inc. - USD -Infinity%
Sage Therapeutics, Inc. 86.45 Million USD 99.092%
Ocugen, Inc. 6.03 Million USD 86.995%
Mind Medicine (MindMed) Inc. - USD -Infinity%
Q32 Bio Inc. 1.15 Million USD 32.093%
Brainstorm Cell Therapeutics Inc. - USD -Infinity%
Alumis Inc. Common Stock - USD -Infinity%
Equillium, Inc. 36.08 Million USD 97.825%
Kyverna Therapeutics, Inc. - USD -Infinity%
Coya Therapeutics, Inc. 6 Million USD 86.921%
CNS Pharmaceuticals, Inc. - USD -Infinity%
Galera Therapeutics, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD -23.993%
Dominari Holdings Inc. 2.03 Million USD 61.501%
Edesa Biotech, Inc. - USD -Infinity%
vTv Therapeutics Inc. - USD -Infinity%
Bio-Techne Corporation 1.15 Billion USD 99.932%
Agios Pharmaceuticals, Inc. 26.82 Million USD 97.073%
Harmony Biosciences Holdings, Inc. 582.02 Million USD 99.865%
Prelude Therapeutics Incorporated - USD -Infinity%
Candel Therapeutics, Inc. - USD -Infinity%
iTeos Therapeutics, Inc. 12.59 Million USD 93.767%
Nkarta, Inc. - USD -Infinity%
BioCardia, Inc. 477 Thousand USD -64.57%
Iterum Therapeutics plc - USD -Infinity%